Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 13 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $7.3M (200,000 shares) of Roivant Sciences Ltd. on Sep 30, 2026. Filing
- Last sale before this period: Oct 15, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Executive Officer, Director | Jul 30, 2025 | Oct 5, 2026 |
| Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Oct 1, 2021 | Oct 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 2, 2026, Immunovant, Inc.: sold 3,506 shares for $120K, to cover taxes. 1 filing: 1
- Oct 1, 2026, Immunovant, Inc.: 92,187 shares vested or acquired by exercising options; 85,886 shares returned to the company. 1 filing: 1
- Sep 30, 2026, Roivant Sciences Ltd.: sold 200,000 shares for $7.3M, under a disclosed plan; 200,000 shares acquired by exercising options. 1 filing: 1
- Aug 28, 2026, Roivant Sciences Ltd.: sold 200,000 shares for $7.2M, under a disclosed plan; 200,000 shares acquired by exercising options. 1 filing: 1
- Aug 20, 2026, Roivant Sciences Ltd.: 13,909 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.